| First Author | Gemperle J | Year | 2019 |
| Journal | Mol Oncol | Volume | 13 |
| Issue | 2 | Pages | 264-289 |
| PubMed ID | 30422386 | Mgi Jnum | J:298789 |
| Mgi Id | MGI:6488740 | Doi | 10.1002/1878-0261.12401 |
| Citation | Gemperle J, et al. (2019) The interaction of p130Cas with PKN3 promotes malignant growth. Mol Oncol 13(2):264-289 |
| abstractText | Protein p130Cas constitutes an adaptor protein mainly involved in integrin signaling downstream of Src kinase. Owing to its modular structure, p130Cas acts as a general regulator of cancer cell growth and invasiveness induced by different oncogenes. However, other mechanisms of p130Cas signaling leading to malignant progression are poorly understood. Here, we show a novel interaction of p130Cas with Ser/Thr kinase PKN3, which is implicated in prostate and breast cancer growth downstream of phosphoinositide 3-kinase. This direct interaction is mediated by the p130Cas SH3 domain and the centrally located PKN3 polyproline sequence. PKN3 is the first identified Ser/Thr kinase to bind and phosphorylate p130Cas and to colocalize with p130Cas in cell structures that have a pro-invasive function. Moreover, the PKN3-p130Cas interaction is important for mouse embryonic fibroblast growth and invasiveness independent of Src transformation, indicating a mechanism distinct from that previously characterized for p130Cas. Together, our results suggest that the PKN3-p130Cas complex represents an attractive therapeutic target in late-stage malignancies. |
